Cardiff Oncology, Inc. (CRDF)
NASDAQ·Healthcare·Biotechnology
$1.56
-2.20%
Mkt Cap $110.07M
Analyst Ratings
Buy
2
Hold
3
Sell
0
Price Target (— analysts)
—
Range — – —
NASDAQ·Healthcare·Biotechnology
$1.56
-2.20%
Mkt Cap $110.07M
Buy
2
Hold
3
Sell
0
Price Target (— analysts)
—
Range — – —